WILLF
Demant A/S
$52.56
+0.00% 2026-10-19
Healthcare
WILLFSPY
1W
+2.7%
1M
+15.4%
3M
+26.6%
6M
+77.3%
YTD
+55.4%
1Y
+46.5%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsDemant (CPSE:DEMANT) Wins On Oticon Reveal, Is The Valuation Already Full?
Simply Wall St. · Oct 13
Best Momentum Stock to Buy for October 2nd
Zacks · Oct 02
New Strong Buy Stocks for October 2nd
Zacks · Oct 02
Bernstein unveils top European medtech stock picks to buy for H2
Investing.com · Sep 25
Demant AS (WILLF) (Q2 2026) Earnings Call Highlights: Strong H1 Growth Fueled by Oticon Zeal ...
GuruFocus.com · Aug 12
Key stats
Market cap$11.1B
P/E (trailing)29.4
P/E (forward)–
52-week range28.08 – 53.08
Revenue growth (YoY, latest qtr)+14.8%
Dividend yield0.00%
Analyst consensusNone
Mean price target–
Valuation and fundamentals
Valuation & fundamentals
No SEC filings found for this ticker (foreign filer, ETF or fund).
Earnings
Next report: 2027-02-02 · during market
No EPS history available.
Stats refreshed 2026-10-20 18:08:59 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.